Latest news
State Street Corporation (ALLO) discloses 5.5% beneficial stake in Allogene - Stock TitanStock Titan · Fri, 07 Aug 2026 12:33:35 GMTAllogene Therapeutics Q2 Results: Earnings Call Set for Aug 12 - scanx.tradescanx.trade · Tue, 04 Aug 2026 18:26:30 GMTAllogene Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update - GlobeNewswireGlobeNewswire · Tue, 04 Aug 2026 12:30:00 GMTAllogene sets Aug. 12 update on cancer and autoimmune disease - Stock TitanStock Titan · Tue, 04 Aug 2026 12:30:00 GMTCell Therapy Weekly: RMAT Designation for Allogeneic CAR-T - RegMedNetRegMedNet · Fri, 31 Jul 2026 21:44:43 GMTCema-Cel Receives FDA RMAT, Fast Track Designations in First-Line LBCL - CancerNetworkCancerNetwork · Thu, 30 Jul 2026 15:07:19 GMTAllogene Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Cemacabtagene Ansegedleucel (Cema-Cel) as First-Line Consolidation Therapy for Large B-Cell Lymphoma - Yahoo FinanceYahoo Finance · Wed, 29 Jul 2026 07:00:00 GMTAllogene Therapeutics' Cemacabtagene Ansegedleucel Receives FDA RMAT, Fast Track Designations - Yahoo FinanceYahoo Finance · Wed, 29 Jul 2026 07:00:00 GMT